The first nationwide surveillance of carbapenem-resistant Enterobacterales in the United Arab Emirates – increased association of Klebsiella pneumoniae CC14 clone with Emirati patients

The first nationwide surveillance of carbapenem-resistant Enterobacterales in the United Arab Emirates – increased association of Klebsiella pneumoniae CC14 clone with Emirati patients

Objectives: To assess the current prevalence, distribution, and main clonal types of carbapenem-resistant Enterobacterales (CRE) in the United Arab Emirates. Methods: A total of 504 CRE collected over a 9-month period in 15 hospitals were studied. Antibiotic susceptibility and the presence of common...

Full description

Bibliographic Details
Main Authors:	Ágnes Sonnevend, Najiba Abdulrazzaq, Akela Ghazawi, Jens Thomsen, Greeshma Bharathan, Lilla Makszin, Tahir A. Rizvi, Tibor Pál
Format:	Article
Language:	English
Published:	Elsevier 2022-07-01
Series:	International Journal of Infectious Diseases
Subjects:	Carbapenem-resistant Enterobacterales Metallo-beta-lactamases Klebsiella pneumoniae ST14 Country-wide surveillance Middle East
Online Access:	http://www.sciencedirect.com/science/article/pii/S1201971222002338

Similar Items

In vitro efficacy of ceftazidime-avibactam, aztreonam-avibactam and other rescue antibiotics against carbapenem-resistant Enterobacterales from the Arabian Peninsula
by: Ágnes Sonnevend, et al.
Published: (2020-10-01)

Early Years of Carbapenem-Resistant <i>Enterobacterales</i> Epidemic in Abu Dhabi
by: Tibor Pál, et al.
Published: (2022-10-01)

Carbapenem resistant Enterobacterales in the United Arab Emirates: a retrospective analysis from 2010 to 2021
by: Jens Thomsen, et al.
Published: (2023-12-01)

Screening for Metallo-Beta-Lactamases Using Non-Carbapenem Agents: Effective Detection of MBL-Producing <i>Enterobacterales</i> and Differentiation of Carbapenem-Resistant <i>Enterobacterales</i>
by: Kentarou Takei, et al.
Published: (2023-07-01)

Hydroxyhexylitaconic acids as potent IMP-type metallo-β-lactamase inhibitors for controlling carbapenem resistance in Enterobacterales
by: Jun-ichi Wachino, et al.
Published: (2024-03-01)

Carbapenem-resistant Enterobacterales in patients with bacteraemia at tertiary academic hospitals in South Africa, 2019 - 2020: An update
by: M Lowe, et al.
Published: (2022-08-01)

The importance of meropenem resistance, rather than imipenem resistance, in defining carbapenem-resistant Enterobacterales for public health surveillance: an analysis of national population-based surveillance
by: Chiaki Ikenoue, et al.
Published: (2024-02-01)

Risk factors for infections caused by carbapenem-resistant Enterobacterales: an international matched case-control-control study (EURECA)Research in context
by: Salvador Pérez-Galera, et al.
Published: (2023-03-01)

Predominance of Non-carbapenemase Producing Carbapenem-Resistant Enterobacterales in South Texas
by: Cody A. Black, et al.
Published: (2021-02-01)

Clinical and molecular characteristics and risk factors for patients acquiring carbapenemase-producing and non-carbapenemase-producing carbapenem-nonsusceptible-Enterobacterales bacteremia
by: Alice Ying-Jung Wu, et al.
Published: (2022-12-01)

Clinical characteristics and treatment outcomes of carbapenem-resistant Enterobacterales infections in Japan
by: Keisuke Oka, et al.
Published: (2022-06-01)

One Health Approach for Reporting Veterinary Carbapenem-Resistant Enterobacterales and Other Bacteria of Public Health Concern
by: Kate KuKanich, et al.
Published: (2023-06-01)

Clinical characteristics and outcomes of carbapenem-resistant Enterobacterales bacteremia in pediatric patients
by: Yu-Cheng Liu, et al.
Published: (2023-02-01)

Effect of Colistin, Fosfomycin and Meropenem/Vaborbactam on Carbapenem-Resistant Enterobacterales in Egypt: A Cross-Sectional Study
by: Shrief R, et al.
Published: (2022-10-01)

Interplay between OXA-10 β-Lactamase Production and Low Outer-Membrane Permeability in Carbapenem Resistance in Enterobacterales
by: Isaac Alonso-García, et al.
Published: (2023-06-01)

In vitro susceptibility of common Enterobacterales to eravacycline in Taiwan
by: Chun-Fu Huang, et al.
Published: (2023-04-01)

In Vitro Activity of Auranofin in Combination With Aztreonam-Avibactam Against Metallo-β-lactamase (MBL)-Producing Enterobacterales
by: Wen Wang, et al.
Published: (2021-10-01)

The burden of carbapenem-resistant Enterobacterales infection in a large Thai tertiary care hospital
by: Watcharaphon Tangsawad, et al.
Published: (2022-09-01)

Carbapenem- and colistin-resistant Enterobacterales in intensive care unit patients in Mediterranean countries, 2019
by: Sandra Dos Santos, et al.
Published: (2024-04-01)

Treatment and Outcomes of Infections Caused by Diverse Carbapenemase-Producing Carbapenem-Resistant Enterobacterales
by: Fang Kang Lim, et al.
Published: (2020-10-01)

The Ever-Worsening Antimicrobial Resistance in Enterobacterales; A wakeup call
by: Fatima Ali, et al.
Published: (2023-04-01)

Epidemiology, risk factors, and clinical outcomes of carbapenem-resistant Enterobacterales in Africa: A systematic review
by: Moloto Kedišaletše, et al.
Published: (2023-12-01)

Cefiderocol, a Siderophore Cephalosporin, as a Treatment Option for Infections Caused by Carbapenem-Resistant Enterobacterales
by: Keith S. Kaye, et al.
Published: (2023-02-01)

Colistin use in a carbapenem-resistant Enterobacterales outbreak at a South African neonatal unit
by: Ilhaam Abrahams, et al.
Published: (2023-01-01)

Geographical differences of carbapenem non-susceptible Enterobacterales and Acinetobacter spp. in Germany from 2017 to 2019
by: Anja von Laer, et al.
Published: (2022-02-01)

Carbapenem alternatives for treatment of bloodstream infections due to AmpC producing enterobacterales
by: M. Ávila-Núñez, et al.
Published: (2023-08-01)

Efficacy and Safety of Ceftazidime-Avibactam for the Treatment of Carbapenem-Resistant Enterobacterales Bloodstream Infection: a Systematic Review and Meta-Analysis
by: Yan Chen, et al.
Published: (2022-04-01)

In vitro and in vivo Antimicrobial Activities of Ceftazidime/Avibactam Alone or in Combination with Aztreonam Against Carbapenem-Resistant Enterobacterales
by: Lu G, et al.
Published: (2022-12-01)

Molecular Characterization of <i>MCR-1</i> Producing <i>Enterobacterales</i> Isolated in Poultry Farms in the United Arab Emirates
by: Ágnes Sonnevend, et al.
Published: (2022-02-01)

Fecal Carriage of Carbapenem Resistant Enterobacterales and Associated Factors Among Admitted Patients in Saint Paul’s Hospital Millennium Medical College, Addis Ababa, Ethiopia
by: Mekonnen Y, et al.
Published: (2023-09-01)

Epidemiology of carbapenem-resistant and carbapenemase-producing Enterobacterales in the Netherlands 2017–2019
by: Cornelia C. H. Wielders, et al.
Published: (2022-04-01)

Prevalence and characteristics of ertapenem-mono-resistant isolates among carbapenem-resistant Enterobacterales in China
by: Yinping Wang, et al.
Published: (2024-12-01)

A Review of Carbapenem Resistance in <i>Enterobacterales</i> and Its Detection Techniques
by: Oznur Caliskan-Aydogan, et al.
Published: (2023-06-01)

Monitoring Carbapenem-Resistant Enterobacterales in the Environment to Assess the Spread in the Community
by: Taro Urase, et al.
Published: (2022-07-01)

Risk Factors for Carbapenem-Resistant Enterobacterales Clinical Treatment Failure
by: Nicholas Rebold, et al.
Published: (2023-02-01)

Prevalence of Carbapenem-Resistant Enterobacterales, Acinetobacter baumannii, and Pseudomonas aeruginosa in a Tertiary Care Hospital in Eastern India: A Pilot Study
by: Gaurav Verma, et al.
Published: (2023-12-01)

Investigating Resistance to Carbapenems in Enterobacterales: A Descriptive Epidemiological Study of 2021 Screening in an Italian Teaching Hospital
by: Erica De Vita, et al.
Published: (2023-09-01)

In vitro activity of aztreonam/avibactam against isolates of Enterobacterales collected globally from ATLAS in 2019
by: Gian Maria Rossolini, et al.
Published: (2022-09-01)

In vitro activity of biapenem and other carbapenems against Russian clinical isolates of Pseudomonas aeruginosa, Acinetobacter spp., and Enterobacterales
by: Kozlov R.S., et al.
Published: (2021-09-01)

Ceftazidime-Avibactam versus Colistin for the Treatment of Infections Due to Carbapenem-Resistant Enterobacterales: A Multicenter Cohort Study
by: Almangour TA, et al.
Published: (2022-01-01)